Status:
COMPLETED
Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus Study
Lead Sponsor:
University of Sao Paulo
Conditions:
Systemic Lupus Erythematosus
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
This research program aims to investigate the clinical, physiological, metabolic and molecular effects of lifestyle change in patients with systemic lupus erythematosus with high cardiovascular risk. ...
Eligibility Criteria
Inclusion
- Women between 18 and 65 years old diagnosed with systemic lupus erythematosus
- one or more high cardiovascular risk factors
- SLEDAI score ≤ 4
- Treatment with prednisone at a dosage \<10 mg/d and treatment with hydroxychloroquine in a stable dose
Exclusion
- another rheumatic diseases (except for secondary Sjogren's syndrome)
- participation in structured exercise training programs and/or prescriptive diets
- illiterate or with diagnosed cognitive disorders or musculoskeletal impairments that potentially compromise understanding and participation in the intervention
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04431167
Start Date
December 1 2020
End Date
August 28 2023
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
São Paulo, São Paulo, Brazil, 05403-010